Skip to main content

Table 3 Description of the patients fulfilling only ACR criteria or only AECG criteria

From: Level of agreement between 2002 American–European Consensus Group and 2012 American College of Rheumatology classification criteria for Sjögren’s syndrome and reasons for discrepancies

Patient Sex Age (years) Duration (years)a Eyeb Mouthc Arthritisd Lunge Neurof Parotidg UWSFh Schirmeri OSSj Chisholmk ANA Anti-SSAl Anti-SSBl RF (n < 0.2) ACPA (n < 20) IgG (mg/l) Clinicalm
Detailed characteristics of the eight patients fulfilling only ACR criteria
1 F 25 0 1 0 0 0 0 0 0.35 8 3 1 160 146 46 0.14 9 9.2 SS
2 F 63 1 1 1 0 0 0 0 0.4 30 3 4 1,280 0 0 0 0 5.8 SS
3 F 34 1 1 0 1 0 0 0 0.2 20 4 4 1,280 174 0 0.5 250 16.2 RA
4 F 59 5 0 1 0 0 0 1 0.4 10 1 3 640 140 80 0.9 7 13.4 SS
5 F 61 5 1 1 0 0 0 0 0.5 8 3 3 0 0 0 0 0 12.1 Sicca
6 F 47 4 1 1 0 0 0 0 0.2 30 3 3 1,280 0 0 0 0 16.5 UCTD
7 F 57 1 1 1 1 0 1 0 0.5 30 4 4 160 0 0 0.52 250 12.7 RA
8 F 27 6 0 1 0 1 0 0 0.25 30 0 3 1,280 100 0 0.81 15 18.9 SLE
Detailed characteristics of the 15 patients fulfilling only AECG criteria
1 F 67 1 1 1 0 0 0 0 0.005 5 2 3 160 0 0 0 0 11.7 SS
2 F 45 1 1 1 0 0 0 0 0.001 5 2 2 640 154 0 0.05 0 13 SS
3 F 75 0 1 1 0 0 0 0 0.2 0 2 3 0 0 0 0.34 0 9.3 SS
4 F 56 1 1 1 0 0 0 0 0.005 25 2 2 1,280 24 152 0 0 9.9 SS
5 F 50 13 1 1 0 0 1 1 0.1 20 0 4 160 0 0 0 0 9.1 SS
6 F 69 6 1 1 0 0 0 0 0.25 5 1 4 1,280 0 0 0 0 10.3 SS
7 F 66 1 1 1 1 0 0 0 0.486 5 2 3 320 0 0 0 0 7 SS
8 F 55 7 1 1 0 1 0 0 0.02 15 2 4 160 0 0 0 0 7.1 SS
9 F 43 3 1 1 0 0 0 0 0.15 5 1 1 640 85 0 0 0 12.6 SS
10 F 78 10 1 1 0 0 0 0 0.05 7 2 3 160 0 0 0 0 9.7 SS
11 M 64 2 1 1 0 1 0 0 0.2 0 0 4 320 0 0 0 28 22.6 SS
12 F 60 8 1 1 0 0 1 1 0.05 5 2 3 640 9 32 0 72 8.43 SS
13 F 58 2 1 1 0 0 0 0 0.04 4 0 3 0 0 0 0 0 8.33 SS
14 F 43 10 0 1 0 0 0 0 0.06 0 1 2 320 40 0 0 0 10 SS
15 F 50 1 1 1 0 0 0 0 0.05 15 1 3 0 0 0 0 0 9.7 SS
  1. ACPA, anti-citrullinated peptide antibodies; ACR, American College of Rheumatology; AECG, American–European Consensus Group; ANA, antinuclear antibody; F, female; IgG, serum level of immunoglobulin G; M, male; OSS, ocular staining score; SS, Sjögren’s syndrome. RA, rheumatoid arthritis; RF, rheumatoid factor; sicca, idiopathic sicca syndrome; SLE, systemic lupus erythematosus; UCTD, undifferentiated connective tissue disease; UWSF, unstimulated whole salivary flow. aDuration of the symptoms. bXerophthalmia (0, absent; 1, present). cXerostomia (0, absent; 1, present). dPresence of swollen and tender joints on the day of examination. eIncludes the presence of chronic dry cough or computed tomography-proven interstitial lung disease. fPatient with objective peripheral neuropathy. gPresence or history of parotidomegaly. hAbnormal if ≤0.1 ml/minute. iSchirmer’s test abnormal if ≤ 5 mm/5 minutes. jAbnormal if ≥ 3. kChisholm’s grading of the lymphocytic infiltration on minor salivary gland biopsy (grades 3 and 4 correspond to a focus score ≥1 focus of more than 50 lymphocytes/4 mm2). lAnti-SSA and anti-SSB antibodies (n < 40). mDiagnosis made by the physician, without reference to specific classification criteria.